Regulatory Approval Process of Biosimilars

General Practice
48 mins
Generics and Biosimilars Initiative (GaBI)
Generics and Biosimilars Initiative (GaBI)
International Federation of Medicine
International Federation of Medicine

Biosimilars are biological medicinal products that are highly similar structurally to a well-established licensed Reference (Comparator) product and there are no clinically meaningful differences between them. However, the regulatory framework which ensures their safety and efficacy is continually evolving in the light of technological advances as well as experience in the licensing and use of bio...

Loading course information...

"Wherever the art of Medicine is loved, there is also a love of Humanity."

— Hippocrates

made with❤️byOmnicuris